RVMD – Revolution Medicines, Inc.
RVMD
$36.79Name : Revolution Medicines, Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $6,852,800,000.00
EPSttm : -4.01
Revolution Medicines, Inc.
$36.79
Float Short %
11.22
Margin Of Safety %
Put/Call OI Ratio
0.78
EPS Next Q Diff
-0.06
EPS Last/This Y
-1.14
EPS This/Next Y
-0.36
Price
36.93
Target Price
72.91
Analyst Recom
1.08
Performance Q
-3.12
Relative Volume
13.16
Beta
1.08
Ticker: RVMD
19 items
«
‹
of 1
›
»
Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
---|---|---|---|---|---|
2025-06-02 | RVMD | 40.66 | 0.54 | 0.16 | 28324 |
2025-06-03 | RVMD | 40.6 | 0.49 | 0.24 | 30915 |
2025-06-04 | RVMD | 40.4 | 0.46 | 0.11 | 31877 |
2025-06-05 | RVMD | 40.21 | 0.46 | 0.55 | 32007 |
2025-06-06 | RVMD | 41.1 | 0.46 | 0.40 | 32378 |
2025-06-09 | RVMD | 40.57 | 0.44 | 0.22 | 33209 |
2025-06-10 | RVMD | 41.98 | 0.42 | 0.93 | 36076 |
2025-06-11 | RVMD | 40.78 | 0.42 | 2.17 | 36638 |
2025-06-12 | RVMD | 41.1 | 0.42 | 0.08 | 36809 |
2025-06-13 | RVMD | 40.59 | 0.42 | 0.70 | 36915 |
2025-06-16 | RVMD | 39.65 | 0.42 | 0.17 | 37149 |
2025-06-17 | RVMD | 39.14 | 0.41 | 0.34 | 37715 |
2025-06-18 | RVMD | 39.93 | 0.41 | 0.30 | 37786 |
2025-06-20 | RVMD | 39.66 | 0.41 | 0.01 | 37762 |
2025-06-23 | RVMD | 40.05 | 0.70 | 0.37 | 23595 |
2025-06-24 | RVMD | 40.05 | 0.68 | 0.02 | 24061 |
2025-06-25 | RVMD | 38.42 | 0.79 | 0.28 | 22092 |
2025-06-26 | RVMD | 37.51 | 0.79 | 1.03 | 22247 |
2025-06-27 | RVMD | 36.92 | 0.78 | 2.22 | 22101 |
Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
19 items
«
‹
Current Page1 of 1
›
»
19 items
«
‹
of 1
›
»
Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
---|---|---|---|---|---|
2025-06-02 | RVMD | 40.67 | -38.4 | -241.2 | -4.65 |
2025-06-03 | RVMD | 40.58 | -38.4 | -195.6 | -4.65 |
2025-06-04 | RVMD | 40.38 | -38.4 | -191.5 | -4.65 |
2025-06-05 | RVMD | 40.20 | -38.4 | -192.0 | -4.65 |
2025-06-06 | RVMD | 41.08 | -38.4 | -226.8 | -4.65 |
2025-06-09 | RVMD | 40.58 | -38.4 | -181.4 | -4.65 |
2025-06-10 | RVMD | 41.99 | -38.4 | -244.3 | -4.65 |
2025-06-11 | RVMD | 40.79 | -38.4 | -160.5 | -4.65 |
2025-06-12 | RVMD | 41.11 | -38.4 | -208.3 | -4.65 |
2025-06-13 | RVMD | 40.62 | -38.4 | -182.1 | -4.65 |
2025-06-16 | RVMD | 39.76 | -38.4 | -170.6 | -4.65 |
2025-06-17 | RVMD | 39.17 | -38.4 | -177.6 | -4.65 |
2025-06-18 | RVMD | 39.93 | -38.4 | -225.2 | -4.65 |
2025-06-20 | RVMD | 39.66 | -38.4 | -188.8 | -4.65 |
2025-06-23 | RVMD | 40.05 | -38.4 | -210.5 | -4.65 |
2025-06-24 | RVMD | 40.03 | -38.4 | -197.7 | -4.65 |
2025-06-25 | RVMD | 38.41 | -38.4 | -143.7 | -4.65 |
2025-06-26 | RVMD | 37.51 | -40.4 | -166.0 | -4.72 |
2025-06-27 | RVMD | 36.93 | -40.4 | -177.8 | -4.72 |
Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
19 items
«
‹
Current Page1 of 1
›
»
18 items
«
‹
of 1
›
»
Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
---|---|---|---|---|
2025-06-02 | RVMD | 5.43 | -0.57 | 11.66 |
2025-06-03 | RVMD | 5.43 | -0.57 | 11.66 |
2025-06-04 | RVMD | 5.43 | -0.57 | 11.66 |
2025-06-05 | RVMD | 5.43 | -0.57 | 11.66 |
2025-06-06 | RVMD | 5.43 | -0.57 | 11.66 |
2025-06-09 | RVMD | 5.43 | -0.50 | 11.66 |
2025-06-10 | RVMD | -0.21 | -0.50 | 11.66 |
2025-06-11 | RVMD | -0.21 | -0.50 | 11.34 |
2025-06-12 | RVMD | -0.21 | -0.50 | 11.34 |
2025-06-13 | RVMD | -0.21 | -0.50 | 11.34 |
2025-06-16 | RVMD | -0.21 | -0.27 | 11.34 |
2025-06-18 | RVMD | -0.30 | -0.27 | 11.34 |
2025-06-20 | RVMD | -0.22 | -0.27 | 11.34 |
2025-06-23 | RVMD | -0.23 | -0.50 | 11.34 |
2025-06-24 | RVMD | -0.23 | -0.50 | 11.34 |
2025-06-25 | RVMD | -0.23 | -0.50 | 11.34 |
2025-06-26 | RVMD | -0.23 | -0.50 | 11.22 |
2025-06-27 | RVMD | -0.23 | -0.50 | 11.22 |
Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
18 items
«
‹
Current Page1 of 1
›
»
Last Quarter Act. EPS
-1.13
Avg. EPS Est. Current Quarter
-1.14
Avg. EPS Est. Next Quarter
-1.19
Insider Transactions
-0.23
Institutional Transactions
-0.5
Beta
1.08
Average Sales Estimate Current Quarter
28
Average Sales Estimate Next Quarter
28
Fair Value
Quality Score
9
Growth Score
18
Sentiment Score
29
Actual DrawDown %
40.8
Max Drawdown 5-Year %
-73.3
Target Price
72.91
P/E
Forward P/E
PEG
P/S
P/B
3.31
P/Free Cash Flow
EPS
-4
Average EPS Est. Cur. Y
-4.72
EPS Next Y. (Est.)
-5.08
Target Price Estimates Raised
1
Target Price Estimates Lowered
Profit Margin
Relative Volume
13.16
Return on Equity vs Sector %
-57.5
Return on Equity vs Industry %
-39.6
EPS 1 7Days Diff
-0.1
EPS 1 30Days Diff
-0.07
EBIT Estimation
-177.8
Sector: Healthcare
Industry: Biotechnology
Employees: 616
Revolution Medicines, Inc., a clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers. The company's research and development pipeline consist of RAS(ON) inhibitors that binds RAS variants to be used as monotherapy in combination with other RAS(ON) inhibitors and/or in combination with RAS companion inhibitors or other therapeutic agents, and RAS companion inhibitors to suppress cooperating targets and pathways that sustain RAS-addicted cancers. Its RAS(ON) inhibitors include daraxonrasib (RMC-6236), elironrasib G12C (RMC-6291), and zoldonrasib G12D (RMC-9805), which are in phase 1 clinical trial; and development candidates comprise RMC-5127 (G12V), RMC-0708 (Q61H), and RMC-8839 (G13C). The company's RAS companion inhibitors include RMC-4630 that is in phase 2 clinical trial; RMC-5552, a selective inhibitor of mTORC1 signaling in tumors, which is in phase 1 clinical trial; and RMC-5845 that targets SOS1. Revolution Medicines, Inc. was incorporated in 2014 and is headquartered in Redwood City, California.
stock quote shares RVMD – Revolution Medicines, Inc. Stock Price stock today
news today RVMD – Revolution Medicines, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch RVMD – Revolution Medicines, Inc. yahoo finance google finance
stock history RVMD – Revolution Medicines, Inc. invest stock market
stock prices RVMD premarket after hours
ticker RVMD fair value insiders trading